美國WaferGen Biosystems, Inc.  www.wafergen.com
先進(jìn)的基因表達(dá)、基因定型、細(xì)胞生物學(xué)和干細(xì)胞研究系統(tǒng)領(lǐng)域領(lǐng)先開發(fā)商 WaferGen Biosystems, Inc. (OTC:WGBS) (BULLETIN BOARD: WGBS)WaferGen生物系統(tǒng)公司是一個(gè)領(lǐng)先的開發(fā)，制造和 出售國家最先進(jìn)的系統(tǒng)的基因表達(dá)，基因，細(xì)胞生物學(xué) 和干細(xì)胞研究的生命科學(xué)和制藥業(yè)。
 

WaferGen Biosystems, Inc. is a leader in the development, manufacture and commercialization of next-generation systems for gene expression, genotyping, stem cell research and cell biology for the life science and pharmaceutical industries. The company is developing what it believes will be the platform of choice for genetic analysis as well as cell monitoring enabling genomics and cell biology from research to clinic. WaferGen’s revolutionary systems are the first of their kind, providing researchers with critical performance advantages that are not available with existing technologies.
WaferGen’s revolutionary systems are the first of their kind, providing researchers with critical performance advantages that are not available with existing technologies.
The company is actively developing its SmartChip™ Real-Time PCR System for the gene expression and genotyping markets. The SmartChip Real-Time PCR System is designed to be the first platform to combine the high-throughput capability and cost efficiencies of existing microarrays, with the sensitivity and accuracy of real-time PCR.
WaferGen currently markets its SmartSlide™ Micro-Incubation family of products to stem cell and cell biology researchers worldwide. The SmartSlide Micro-Incubation System is a first-of- its-kind family of integrated fluidics exchange micro-incubation products with innovative capabilities designed to allow researchers to pursue cutting-edge research topics that are not addressable with existing technology.